ZOM צמיחה צפויה ברווח למניה לשנה הבאה Zomedica

לוגו תאגידי של חברת Zomedica Corp (ZOM)

Zomedica Corp. (ZOM) is implementing Inertia platforms based on a "razor-and-blade" model, ensuring long-term demand for cartridges. The company's EPS trajectory for the coming year correlates with these volumes, while 0.00 reflects the latest metric value. Revenues are based on the sale of veterinary rapid analyzers. Management is currently optimizing distribution, aiming to drive the business toward stable profitability for investors.

ZOM: צמיחה צפויה ברווח למניה לשנה הבאה Zomedica Corporation 04.07.2022 - 15.03.2025

Zomedica Corporation - פילוחים אנליטיים ומדדי מפתח (ZOM)

- מחיר מניה וקונצנזוס הערכת שווי:
אנליטיקה מסכמת של החברה:Zomedica Corporation
מוצר עיקרי של Zomedica Corp

This indicator reflects the trend of analysts' consensus net income forecasts for the coming year, allowing for an assessment of the asset's fundamental value vector in light of industry cycles. By analyzing the history of forward earnings per share estimates, an investor can see the impact of the Zomedica Corp. (ZOM) outsourcing model, where shifting production to external plants while retaining R&D rights reduces capital expenditures and optimizes expected returns.